Zhengjie Kong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zhengjie Kong has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Bo Wan
International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan, China; Ministry of Education Key Laboratory for Animal Pathogens and Biosafety, Henan Agricultural University, Zhengzhou, China
3 shared publications Xueke Sun
College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan, China; International Joint Research Center for National Animal Immunology, Zhengzhou, Henan, China
3 shared publicationsDengkun Wang
International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan, China; Ministry of Education Key Laboratory for Animal Pathogens and Biosafety, Henan Agricultural University, Zhengzhou, China
2 shared publications- Gaiping Zhang
International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China
2 shared publications Huihui Huang
International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan, China; Ministry of Education Key Laboratory for Animal Pathogens and Biosafety, Henan Agricultural University, Zhengzhou, China
2 shared publicationsJiahao Cong
International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan, China; Ministry of Education Key Laboratory for Animal Pathogens and Biosafety, Henan Agricultural University, Zhengzhou, China
2 shared publications
Latest Publications
A nanoparticle vaccine targeting glycoprotein D induces immune protection against pseudorabies virus
- 21 December 2025
- Published by Elsevier in Veterinary Microbiology
- Vol. 313, 110849
PEDV nonstructural protein 14 inhibits RIPK3 and RIPK1-mediated PANoptosis
- 21 December 2025
- Published by Elsevier in Veterinary Microbiology
- Vol. 313, 110849
PEDV nonstructural protein 14 inhibits RIPK3 and RIPK1-mediated PANoptosis
- 18 December 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 338 (Pt 2) , 149760
λ-Carrageenan regulates antiviral responses by targeting classical NF-κB and IRF3-mediated signaling pathways
- 18 December 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 338 (Pt 2) , 149760
λ-Carrageenan regulates antiviral responses by targeting classical NF-κB and IRF3-mediated signaling pathways
- 9 May 2025
- Published by Elsevier in Veterinary Microbiology
- Vol. 306, 110547
Senecavirus A nonstructural protein 3A Inhibits Ago2-mediated RNAi antiviral response
- 9 May 2025
- Published by Elsevier in Veterinary Microbiology
- Vol. 306, 110547
Senecavirus A nonstructural protein 3A Inhibits Ago2-mediated RNAi antiviral response
- Open Access
Pseudorabies Virus Tegument Protein UL13 Suppresses RLR-Mediated Antiviral Innate Immunity through Regulating Receptor Transcription
Pseudorabies virus (PRV) has evolved various strategies to escape host antiviral immune responses. However, it remains unclear whether and how PRV-encoded proteins modulate the RIG-I-like receptor (RLR)-mediated signals for immune evasion. Here, we show that the PRV tegument protein UL13 functions as an antagonist of RLR-mediated antiviral responses via suppression of the transcription of RIG-I and MDA5, but not LGP2. UL13 overexpression significantly inhibits both the mRNA and protein levels of RIG-I and MDA5, along with RIG-I- or MDA5-mediated antiviral immune responses, whereas overexpression of RIG-I or MDA5 counteracts such UL13-induced suppression. Mechanistically, UL13 suppresses the expression of RIG-I and MDA5 by inhibiting activation of the transcription factor NF-κB. Consequently, overexpression of p65 promotes the activation of RIG-I and MDA5 promoters. Moreover, deletion of the p65-binding sites in the promoters of RIG-I or MDA5 abolishes the suppression role of UL13. As a result, mutant PRV lacking UL13 elicits stronger host antiviral immune responses than PRV-WT. Hence, our results provide a novel functional role of UL13-induced suppression of host antiviral immunity through modulating receptors’ transcription.
Open AccessPseudorabies Virus Tegument Protein UL13 Suppresses RLR-Mediated Antiviral Innate Immunity through Regulating Receptor Transcription
Pseudorabies virus (PRV) has evolved various strategies to escape host antiviral immune responses. However, it remains unclear whether and how PRV-encoded proteins modulate the RIG-I-like receptor (RLR)-mediated signals for immune evasion. Here, we show that the PRV tegument protein UL13 functions as an antagonist of RLR-mediated antiviral responses via suppression of the transcription of RIG-I and MDA5, but not LGP2. UL13 overexpression significantly inhibits both the mRNA and protein levels of RIG-I and MDA5, along with RIG-I- or MDA5-mediated antiviral immune responses, whereas overexpression of RIG-I or MDA5 counteracts such UL13-induced suppression. Mechanistically, UL13 suppresses the expression of RIG-I and MDA5 by inhibiting activation of the transcription factor NF-κB. Consequently, overexpression of p65 promotes the activation of RIG-I and MDA5 promoters. Moreover, deletion of the p65-binding sites in the promoters of RIG-I or MDA5 abolishes the suppression role of UL13. As a result, mutant PRV lacking UL13 elicits stronger host antiviral immune responses than PRV-WT. Hence, our results provide a novel functional role of UL13-induced suppression of host antiviral immunity through modulating receptors’ transcription.